PRESS
FOR IMMEDIATE RELEASE
October 9, 2025 – Washington, USA
Esmé SX Completes Blitz Build, Appoints Reza Eghbal as Chief Technology Officer
Esmé SX Corp, a neuroadaptive technology company advancing the science of emotional and biometric intelligence, today announced the successful completion of its eight-week Blitz Build, marking a key milestone toward the company’s 2026 product and clinical launch objectives.
The Blitz Build unified Esmé’s multi-vertical platform—spanning intimacy, mobility, immersive environments, and robotics—under a single deterministic AI architecture. The achievement establishes technical reproducibility and compliance readiness across all system proofs.
“We set out to prove that emotional intelligence in machines could be deterministic, ethical, and human-true,” said Chelsey Moss, Founder & CEO of Esmé SX. “The Blitz Build brings that proof to life. Our systems now speak a shared emotional-biometric language that scales safely across every environment we touch.”
“Governance isn’t a slide, it’s code,” added Reza Eghbal, Chief Technology Officer. “We compiled consent, bias controls, and audit trails into the pipeline from day one.”
Core Outcomes of the Blitz Build
Deterministic Core: Verified, byte-identical proofs across intimacy, automotive, VR, and robotics systems.
Unified Schema: One emotional-biometric ontology (LUMEX) integrating physiological and affective data streams.
Governance in Code: Consent, bias control, and audit trails embedded directly into the stack via Ethics OS and Intent Layer.
Bias Mitigation & Data Diversity: Every dataset and proof run incorporates cross-cohort sampling, fairness gating, and QA validation to ensure equitable model behavior across bodies and contexts.
NIH-Ready Dataset: A validated, bias-controlled research package supporting forthcoming clinical collaborations.
Leadership Appointment
Esmé SX also announced the appointment of Reza Eghbal as Chief Technology Officer, effective immediately.
Eghbal will lead AI systems architecture, SDK and hardware integration, compliance readiness, and partner enablement across Esmé’s verticals. His role encompasses guiding the company’s AI development, signal architecture, and partner-facing SDK programs through the next stage of scale and commercialization.
A Python programmer and AI developer specializing in healthcare information technology, Eghbal brings extensive experience in health information exchange, machine learning, blockchain, and health-focused big-data mining. His work centers on Health 4.0, wearable data pipelines, IoT integration, and real-time health monitoring, with a strong commitment to bias-resistant, data-diverse healthcare systems and equitable model design. He is passionate about advancing proactive healthcare strategies and health equity through innovative, scalable solutions that integrate gamified pathways to boost patient engagement and collaboration in healthcare transformation.
This appointment recognizes Eghbal’s pivotal leadership in completing the Blitz Build and formalizes his role as the company advances toward its Seed Round and early commercialization phase.
Looking Ahead
Over the next 90 days, Esmé SX will focus on:
SDK v1 rollout to strategic partners
Consent Ledger MVP and compliance infrastructure
Nova prototype fabrication and validation testing
MindMics API integration and chipset evaluation
Preparations for NIH-style Phase I pilot study
About Esmé SX Corp
Esmé SX Corp is pioneering embodied biometric intelligence through a rights-bound, neuroadaptive technology stack that unites emotion, physiology, and AI. Its platform spans multiple verticals—intimacy, performance health, mobility, and immersive environments—under a single ethical and reproducible architecture.
For more information, visit esmesx.com.
Press Release
FOR IMMEDIATE RELEASE
Washington, USA — September 12, 2025
Esmé SX Unveils Neuroadaptive AI Platform Spanning Intimacy, Wellness, Automotive, Robotics, and Clinical Care
Technology company unveils its proprietary architecture — protected by a growing portfolio of patent filings — marking a new era of adaptive, emotional, and physiologically-verified human–machine interaction.
Washington, USA — Esmé SX, a technology company pioneering the future of neuroadaptive AI systems, today announced the official unveiling of its platform architecture. The announcement marks Esmé SX’s emergence from stealth and its expansion across four verticals: intimacy and wellness, automotive, robotics and immersive environments, and clinical and therapeutic care.
At its core, the Esmé SX Platform integrates neuroadaptive AI, multi-modal biometric sensing, and adaptive multi-sensory modulation into a unified ecosystem. The architecture is both elegant and defensive — combining Edge-first processing with a built-in physiological truth filter that ensures every signal is verified at capture and impossible to fake.
A New Standard for Human–Machine Interaction
“Technology should feel alive — attuned to the body, to our rhythms, and to our emotions,” said Chelsey Moss, Founder & CEO of Esmé SX. “Esmé SX is building the next interface: systems that don’t just respond, but resonate. This unveiling signals the category we are creating.”
At the center of the platform is the Esmé Protocol — the company’s rights-bound data framework that binds consent, cryptographic provenance, and ownership to every frame of biometric data. This foundation ensures security, compliance, and scalability across regulated environments.
Vertical Applications
SX Modal One (Intimacy & Wellness): A luxury-precision pleasure technology device that adapts to physiology and emotion in real time through precision haptic, thermal, and acoustic stimulation.
Esmé Drive (Automotive): Transforms vehicles into adaptive sensory ecosystems that sharpen focus, ease tension, and elevate comfort through in-seat, in-cabin, and environmental integration.
MIRROR OS (Robotics & VR): Brings emotional intelligence to humanoid robotics and immersive VR/AR, enabling lifelike, adaptive interactions.
Clinical & Therapeutic Systems: Edge-first neuroadaptive solutions designed for IRB-style pilots and clinical integration, supporting applications from pelvic floor rehabilitation to trauma-informed recovery.
Protected and Positioned for Scale
Esmé SX holds multiple provisional patents across biometric-responsive systems, emotional AI modeling, and adaptive multi-sensory architectures. With an exclusive biometric ingestion partnership with MindMics, Esmé SX is positioned to lead as the de-facto standard in neuroadaptive human–machine interaction.
About Esmé SX
Esmé SX is a Washington-based technology company developing neuroadaptive AI systems that harmonize physiology, emotion, and environment in real time. The platform spans intimacy, wellness, automotive, robotics, and clinical care — uniting scientific rigor, elegant design, and a devotion to the intelligence of the human body.
Esmé SX Featured in Snatch Health’s Performance Player Spotlight
September 2025
Esmé SX was selected for inclusion in Snatch Health’s Fall 2025 Market Intelligence Report — The Pleasure Principle, recognized within the Performance Player Spotlight for pioneering the integration of sexual wellness and autonomic nervous system (ANS) optimization. The feature highlights our proprietary biometric-responsive platform and positions Esmé SX as a category leader in precision performance health.
Strategic Milestone: Esmé SX Releases AI Core v3 and Files Third U.S. Patent
July 2025
Esmé SX has completed development of AI Core v3, the next-generation intelligence layer for biometric-responsive systems, and filed its third U.S. patent — expanding our platform into the automotive sector with Esmé Drive. This milestone marks our transition from a single flagship device to a cross-vertical architecture capable of powering adaptive feedback and closed-loop modulation across multiple industries.
Esmé SX Featured in Abigail Miller’s Industry White Paper: Turning Stigma into Strategy: Marketing Lessons from 63 Entrepreneurs in Sexual Wellness and Women’s Health.
May 2025
Esmé SX is honored to be profiled in Abigail Miller’s Turning Stigma into Strategy: Marketing Lessons from 63 Entrepreneurs in Sexual Wellness and Women’s Health. The report showcases founders redefining women’s health through scientific rigor, design innovation, and strategic market positioning. As quoted in the report:
“We are redefining the entire category of sexual wellness by focusing on the mind-body connection and offering an intelligent, sophisticated alternative to ‘sex toys.’ We’re not here for toys. We’re here to help women reclaim their power and deepen their self-awareness.”
Esmé SX Releases White Paper: Advancing Women’s Health & Wellness Through Innovation
February 2025
Esmé SX has published its first white paper, Advancing Women’s Health & Wellness Through Innovation, outlining a science-backed vision for closing the women’s health gap through research-driven product development, advanced technology integration, and holistic care. The paper details our proprietary multimodal stimulation architecture — integrating acoustic wave technology, thermoacoustic effects, AI-driven personalization, real-time biometric feedback via our exclusive MindMics partnership, and dynamic haptics — to redefine sexual wellness as an essential domain of health.
Esmé SX Partners with MindMics to Integrate Exclusive Biometric Sensing
January 2025
Esmé SX has entered into an exclusive strategic partnership with MindMics to integrate their infrasonic biometric sensing technology into the SX Modal One and across our neuroadaptive platform. This collaboration enhances physiological signal fidelity and enables unprecedented real-time responsiveness across applications in intimacy, wellness, and performance health.